AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board....

|By:, SA News Editor

AngioDynamics (ANGO -5.8%) takes a hit after its FQ2 earnings missed the mark across the board. Profit fell 29% Y/Y, primarily due to costs related to a recall of some its NeverTouch procedure kits. Gross margin was also down, reflecting the impact of ongoing programs to reduce material costs and increase its manufacturing efficiency.